Edwards Lifesciences Return on Tangible Equity 2010-2025 | EW
Current and historical return on tangible equity values for Edwards Lifesciences (EW) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Edwards Lifesciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $4.15B | $7.66B | 57.11% |
| 2025-03-31 | $4.18B | $7.24B | 61.18% |
| 2024-12-31 | $4.18B | $7.11B | 65.28% |
| 2024-09-30 | $4.16B | $7.05B | 70.35% |
| 2024-06-30 | $1.47B | $5.94B | 27.28% |
| 2024-03-31 | $1.41B | $5.49B | 27.76% |
| 2023-12-31 | $1.40B | $5.18B | 29.23% |
| 2023-09-30 | $1.43B | $5.00B | 31.14% |
| 2023-06-30 | $1.39B | $4.72B | 30.59% |
| 2023-03-31 | $1.49B | $4.31B | 33.24% |
| 2022-12-31 | $1.52B | $4.36B | 33.89% |
| 2022-09-30 | $1.46B | $4.79B | 32.51% |
| 2022-06-30 | $1.46B | $4.46B | 33.83% |
| 2022-03-31 | $1.54B | $4.36B | 37.58% |
| 2021-12-31 | $1.50B | $4.34B | 39.60% |
| 2021-09-30 | $1.48B | $4.05B | 42.51% |
| 2021-06-30 | $1.46B | $3.64B | 46.56% |
| 2021-03-31 | $0.85B | $3.16B | 30.20% |
| 2020-12-31 | $0.82B | $3.07B | 31.34% |
| 2020-09-30 | $0.79B | $2.71B | 31.48% |
| 2020-06-30 | $0.74B | $2.34B | 30.81% |
| 2020-03-31 | $1.11B | $2.40B | 47.85% |
| 2019-12-31 | $1.05B | $2.64B | 47.24% |
| 2019-09-30 | $0.77B | $2.28B | 39.16% |
| 2019-06-30 | $0.73B | $1.94B | 39.19% |
| 2019-03-31 | $0.77B | $2.00B | 43.53% |
| 2018-12-31 | $0.72B | $1.69B | 43.45% |
| 2018-09-30 | $0.71B | $1.77B | 45.03% |
| 2018-06-30 | $0.66B | $1.58B | 41.52% |
| 2018-03-31 | $0.56B | $1.62B | 35.47% |
| 2017-12-31 | $0.58B | $1.36B | 38.29% |
| 2017-09-30 | $0.75B | $1.77B | 45.73% |
| 2017-06-30 | $0.72B | $1.57B | 43.37% |
| 2017-03-31 | $0.66B | $1.40B | 39.39% |
| 2016-12-31 | $0.57B | $1.79B | 33.82% |
| 2016-09-30 | $0.55B | $1.86B | 33.34% |
| 2016-06-30 | $0.53B | $1.63B | 33.27% |
| 2016-03-31 | $0.52B | $1.47B | 31.09% |
| 2015-12-31 | $0.50B | $1.67B | 28.34% |
| 2015-09-30 | $0.46B | $1.59B | 26.05% |
| 2015-06-30 | $0.44B | $1.90B | 24.60% |
| 2015-03-31 | $0.87B | $1.83B | 51.74% |
| 2014-12-31 | $0.81B | $1.79B | 55.40% |
| 2014-09-30 | $0.78B | $1.64B | 59.88% |
| 2014-06-30 | $0.76B | $1.50B | 66.84% |
| 2014-03-31 | $0.31B | $0.92B | 29.22% |
| 2013-12-31 | $0.39B | $1.13B | 35.39% |
| 2013-09-30 | $0.40B | $0.99B | 37.50% |
| 2013-06-30 | $0.40B | $1.13B | 35.63% |
| 2013-03-31 | $0.37B | $1.15B | 34.23% |
| 2012-12-31 | $0.29B | $1.03B | 28.03% |
| 2012-09-30 | $0.27B | $1.13B | 26.20% |
| 2012-06-30 | $0.25B | $1.02B | 25.74% |
| 2012-03-31 | $0.24B | $0.98B | 25.10% |
| 2011-12-31 | $0.24B | $0.92B | 25.28% |
| 2011-09-30 | $0.24B | $0.94B | 25.46% |
| 2011-06-30 | $0.24B | $0.96B | 25.63% |
| 2011-03-31 | $0.24B | $0.93B | 27.38% |
| 2010-12-31 | $0.22B | $0.93B | 26.92% |
| 2010-09-30 | $0.20B | $0.85B | 26.20% |
| 2010-06-30 | $0.23B | $0.73B | 31.22% |
| 2010-03-31 | $0.22B | $0.75B | 31.27% |
| 2009-12-31 | $0.23B | $0.76B | 35.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $46.340B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.160B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $171.782B | 71.20 |
| IDEXX Laboratories (IDXX) | United States | $50.940B | 53.01 |
| Alcon (ALC) | Switzerland | $44.451B | 29.84 |
| IQVIA Holdings (IQV) | United States | $32.700B | 18.48 |
| DexCom (DXCM) | United States | $31.725B | 47.59 |
| Mettler-Toledo (MTD) | United States | $27.244B | 32.34 |
| STERIS (STE) | Ireland | $24.388B | 25.96 |
| Waters (WAT) | United States | $17.722B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.000B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.416B | 26.74 |
| Globus Medical (GMED) | United States | $8.261B | 19.06 |
| Masimo (MASI) | United States | $7.973B | 26.83 |
| Teleflex (TFX) | United States | $5.493B | 8.87 |
| Glaukos (GKOS) | United States | $5.221B | 0.00 |
| TransMedics (TMDX) | United States | $4.182B | 63.56 |
| Integer Holdings (ITGR) | United States | $3.723B | 18.58 |
| LivaNova (LIVN) | United Kingdom | $2.920B | 16.71 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| Veracyte (VCYT) | United States | $2.326B | 32.14 |
| PROCEPT BioRobotics (PRCT) | United States | $2.210B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.118B | 25.29 |
| Artivion (AORT) | United States | $1.983B | 100.05 |
| Elekta AB (EKTAY) | Sweden | $1.850B | 17.30 |
| Integra LifeSciences Holdings (IART) | United States | $1.145B | 6.56 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.067B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.736B | 0.00 |
| AxoGen (AXGN) | United States | $0.707B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.690B | 0.00 |
| SiBone (SIBN) | United States | $0.668B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.530B | 9.37 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.472B | 3.79 |
| Treace Medical Concepts (TMCI) | United States | $0.454B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.386B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.369B | 88.00 |
| RxSight (RXST) | United States | $0.360B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.287B | 19.78 |
| NeuroPace (NPCE) | United States | $0.273B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.229B | 0.00 |
| Neuronetics (STIM) | United States | $0.223B | 0.00 |
| 908 Devices (MASS) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Inogen (INGN) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.141B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.108B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.081B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.075B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 22.67 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.22 |